Komori
Other Disclosures3992Needs Well Inc.Information and Communications, Services and Others

Support for optimizing operating costs at the Pharmaceuticals and Medical Devices Agency

ニーズウェル will provide a license configuration tailored to the required functions and scale of use for the AI-OCR solution used by the Pharmaceuticals and Medical Devices Agency (PMDA), supporting the optimization of operating costs.

Worth reading
64In focus
Scored from 4 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

AI-OCR solution
Applicable field (uses covered by this announcement)

Conversion of image information into text data, data entry and data processing in PMDA's operations

What the company reported numerically
Usage history

PMDA's usage to date. Specific number of cases and period are Not disclosed.

Relationship between the counterparty and the company
Needs Well Inc.3992
Relationship with the Company

A business relationship in which the company provides the license configuration for the AI-OCR solution used by PMDA in its operations.

CounterpartyPharmaceuticals and Medical Devices Agency (PMDA), an independent administrative agency

Incorporated administrative agency. Other information, including location, representative, business activities, capital and year established, is Not disclosed.

Offering price

A competitively priced license configuration. Specific pricing and fee structure are Not disclosed.

Impact on Business Performance

The specific amount of the impact on results is Not disclosed. The company plans to use this to secure new projects and grow its solutions business.

The company does not address Contract Value.

Announced details
ItemDetails
Names of Products / Services CoveredAI-OCR solution
CounterpartyPharmaceuticals and Medical Devices Agency (PMDA), an independent administrative agency
Counterparty overviewIncorporated administrative agency. Other information, including location, representative, business activities, capital and year established, is Not disclosed.
Relationship with the CompanyA business relationship in which the company provides the license configuration for the AI-OCR solution used by PMDA in its operations.
Offering priceA competitively priced license configuration. Specific pricing and fee structure are Not disclosed.
Applicable areaConversion of image information into text data, data entry and data processing in PMDA's operations
Usage historyPMDA's usage to date. Specific number of cases and period are Not disclosed.
Impact on Business PerformanceThe specific amount of the impact on results is Not disclosed. The company plans to use this to secure new projects and grow its solutions business.
Items this document does not state (10)
Contract ValueContract DateLaunch dateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

PMDA will review the license configuration according to the required functions and scale of use, based on its usage to date.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Support for optimizing operating costs at the Pharmaceuticals and Medical Devices Agency | Needs Well Inc. (3992) timely disclosure | Komori